|1.||Sudo, Tatsuhiko: 3 articles (01/2007 - 02/2003)|
|2.||Ma, Shumei: 2 articles (10/2015 - 12/2013)|
|3.||Liu, Xiaodong: 2 articles (10/2015 - 12/2013)|
|4.||Liang, Nan: 2 articles (10/2015 - 12/2013)|
|5.||Lundgreen, Abbie: 2 articles (01/2015 - 01/2011)|
|6.||Wolff, Roger K: 2 articles (01/2015 - 01/2011)|
|7.||Slattery, Martha L: 2 articles (01/2015 - 01/2011)|
|8.||Cheng, Yu-Jen: 2 articles (12/2013 - 06/2013)|
|9.||Wu, Yang-Chang: 2 articles (12/2013 - 06/2013)|
|10.||Chen, Yun-Ju: 2 articles (12/2013 - 06/2013)|
12/01/2013 - "WYC02-9 inhibited cervical cancer cell migration/invasion and angiogenesis in vitro and in vivo via MAPK14 pathway. "
12/01/2013 - "The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling."
12/01/2013 - "Human cervical cancer cells, Hela, were used, and cell models with ATM(-/-) and MAPK14(-/-) were established by gene engineering. "
06/13/2013 - "WYC02-9 exerts its anti-tumor effect via ROS/MAPK14-induced apoptosis and has the potential to be developed as a chemotherapeutic agent for CRC."
06/13/2013 - "An in vivo xenograft study revealed that WYC02-9 enhanced MAP2K3/6 and MAPK14 phosphorylation, induced apoptosis, and suppressed CRC tumor growth. "
02/01/2011 - "Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation."
07/01/2007 - "Activation of MAPK1/3 and MAPK14 were accompanied by an increase in B-cell leukemia/lymphoma (BCL) 2 levels in both cytosolic and mitochondrial fractions of testicular lysates (BAX levels remained unaffected) and cytochrome c and DIABLO release from mitochondria. "
|3.||Liver Neoplasms (Liver Cancer)
06/01/2007 - "Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. "
09/01/2013 - "There is a novel positive autoregulatory feedback loop underlying the interaction between YAP and CREB in liver cancer, suggesting that YAP and CREB form a nexus to integrate the protein kinase A, Hippo/YAP, and MAPK14/p38 pathways in cancer cells and thus may be helpful in the development of effective diagnosis and treatment strategies against liver cancer."
04/01/2008 - "Pyridinyl and pyrimidinyl imidazoles, selectively inhibit p38alpha MAP kinase, are useful in the treatment of inflammatory diseases like rheumatoid arthritis. "
10/22/2009 - "p38alpha MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFalpha and IL-1beta at a translational and transcriptional level. "
|5.||T-Cell Lymphoma (Lymphoma, T Cell)
|1.||Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
|2.||sorafenib (BAY 43-9006)
|5.||Mitogen-Activated Protein Kinase 14
|8.||Protein Kinases (Protein Kinase)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)
|3.||Hematopoietic Stem Cell Transplantation